We are live on ! Find out more
SQZ

SQZ Biotechnologies Company

Delisted

SQZ was delisted on the 3rd of July, 2023.

36 hedge funds and large institutions have $234M invested in SQZ Biotechnologies Company in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+36
Holders Change %
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$61K +$53.6K +2,100 New
SO
27
STRS Ohio
Ohio
$31K +$28.1K +1,100 New
UBS Group
28
UBS Group
Switzerland
$27K +$23.7K +930 New
Citigroup
29
Citigroup
New York
$24K +$20.9K +820 New
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$19K +$17.9K +700 New
TRCT
31
Tower Research Capital (TRC)
New York
$13K +$11K +432 New
Legal & General Group
32
Legal & General Group
United Kingdom
$13K +$11.2K +439 New
AIP
33
Ameritas Investment Partners
Nebraska
$11K +$9.52K +373 New
HI
34
Hudock Inc
Pennsylvania
$10K +$8.93K +350 New
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$8K +$7.48K +293 New
AIG
36
American International Group
New York
$75 +$66.1K +2,588 New

SQZ Hedge Fund Activity: Q4 2020 in Review

36 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q4 2020, worth a combined $234M.

Buyers outnumbered sellers: 36 funds opened new SQZ positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Temasek Holdings, opening a new position worth an estimated $64.2M.

  • 36 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $234M of SQZ Biotechnologies Company stock for Q4 2020.
  • 36 funds opened new SQZ Biotechnologies Company positions in Q4 2020 and 0 closed out, a net change of +36 holders.
  • The largest SQZ Biotechnologies Company buyer in Q4 2020 was Temasek Holdings, an estimated $64.2M added.

Based on aggregated 13F filings for Q4 2020.